(Q46734808)

24 December 2017

title

Side effects of ketamine in the long-term treatment of neuropathic pain (English)

1 reference

24 December 2017

0 references

Petr Cvrcek

1

1 reference

24 December 2017

publication date

1 March 2008

1 reference

24 December 2017

published in

Pain Medicine

1 reference

24 December 2017

volume

9

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

253-257

1 reference

24 December 2017

Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: a challenge for the radiation oncologist

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Pain and dysesthesia in patients with spinal cord injury: A postal survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Ketamine hydrochloride in the treatment of phantom limb pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Low-dose subcutaneous ketamine infusion and morphine tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Changes in serum enzyme levels following ketamine infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00314.X

10.1111/J.1526-4637.2007.00314.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18298710

1 reference

24 December 2017